Tumor Lysis Syndrome (TLS)

Tumor lysis syndrome is a rare condition that can happen due to the rapid death of cancer cells.

Immune Thrombocytopenic Purpura (ITP)

Immune thrombocytopenic purpura (ITP) is a rare but serious complication that happens in an estimated 1-5% of those living with CLL and SLL.

Measurable Residual Disease (MRD)

Measurable residual disease (MRD) testing measures the amount of cancer cells that are present in blood or bone marrow at the time the sample was collected.

My CLL is Not Gone; Close, but Not Gone

My CLL wasn’t detectable in my bloodstream after about six months in my epcoritamab trial, it almost certainly was still hiding below the level of detection.

Test Before Treat Handout

A one page summary of what you need to know about the 3 most important tests that need to be done to guide your CLL treatment.

Cancer Related Fatigue

Fatigue is one of the most common symptoms experienced by those living with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), and it is also commonly overlooked, underreported, and undertreated.

TARGETED ORAL TREATMENT OPTIONS

Targeted oral treatment options for CLL and SLL are medications taken by mouth that identify and attack specific cancer cells.

Didn't find what you where looking for?

Try our advanced search page!